Thrivent Financial for Lutherans
ANAB icon

Thrivent Financial for Lutherans’s AnaptysBio ANAB Stock Holding History

Thrivent Financial for Lutherans’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-12,812
Closed -$276K – 2454
2021
Q1 		$276K Sell
12,812
-68,305
-84% -$1.72M ﹤0.01% 2408
2020
Q4 		$1.74M Hold
81,117
– – ﹤0.01% 1403
2020
Q3 		$1.2M Sell
81,117
-15,950
-16% -$288K ﹤0.01% 1462
2020
Q2 		$2.17M Sell
97,067
-4,959
-5% -$90.7K 0.01% 1013
2020
Q1 		$1.44M Buy
+102,026
New +$1.55M 0.01% 1109

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Thrivent Financial for Lutherans's ANAB Position: Q2 2021 in Review

Thrivent Financial for Lutherans sold out of AnaptysBio (ANAB) in Q2 2021, closing a stake of 12,812 shares — an estimated $276K sold.

Thrivent Financial for Lutherans first reported a position in ANAB in Q1 2020 and held it in 5 quarters. The position peaked at $2.17M in Q2 2020. 122 funds tracked by Wall St. Rank hold ANAB as of Q2 2021.

  • Thrivent Financial for Lutherans reported no remaining AnaptysBio position as of Q2 2021 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 12,812 AnaptysBio shares in Q2 2021, an estimated $276K.
  • Thrivent Financial for Lutherans first reported a position in AnaptysBio in Q1 2020 and held it in 5 quarters.
  • Thrivent Financial for Lutherans's AnaptysBio position peaked at $2.17M in Q2 2020.
  • 122 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2021.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2021, filed 19 Aug 2021.